L
ipopolysaccharide is the major constituent of the outer membrane of Gram-negative bacteria. Elucidation of the molecular mechanisms responsible for the interaction of LPS with mammalian responsive cells (macrophages, neutrophils, and monocytes) has been the major subject of intensive study during the last decade. LPS aggregates bind LPS binding protein (LBP) 3 in the serum and then are transferred to either membranebound or soluble CD14 (1) . Membrane-bound CD14 also has been shown to internalize LPS (1) . CD14 is unable to transduce a signal across the cell membrane; therefore, Toll-like receptor (TLR)-4 and TLR-2 have been suggested to be the signal-transducing proteins or coreceptors (2, 3) . However, transfection of TLR-4 did not confer LPS responsiveness to a recipient Ba/F3 cell line, and MD-2 recently has been postulated to be the link between TLR-4 and LPS signaling (4) . LPS also can activate cells via a CD14-independent pathway (1) . LPS activates a cascade of proinflammatory cytokines, including TNF, IL-1, and IL-6, that when produced in excess can lead to septic shock (5) . Highly purified LPS is crucial for studying its biological activity in vitro; however, the only rough LPS purified to near homogeneity, well-characterized, and suitable for biological study is the hexaacyl deep rough chemotype LPS from Escherichia coli D31 m4 (ReLPS; Ref. 6 ). Standard commercial preparations of ReLPS are structurally heterogeneous and are contaminated with proteins and give rise to confounding results as shown previously (7) .
Diphosphoryl lipid A from Rhodobacter sphaeroides (RsDPLA) is the first potent antagonist of toxic ReLPS in both human and murine cells and also prevents LPS-induced shock in mice (8) . Qureshi et al. (6, 9) have purified RsDPLA and completed the structural analysis of this lipid A. The structures of both agonist (ReLPS) and antagonist (RsDPLA) are presented in Fig. 1 . RsDPLA blocks both the CD14-dependent and the CD14-independent pathway for the activation of immune cells by LPS. RsDPLA effectively competes with LPS for binding to LBP and soluble CD14 (10) , and RsDPLA also blocks the binding of iodinated ReLPS to the cell (11) . However, others have shown that LPS from R. sphaeroides (RsLPS) does not prevent the binding of LPS-BODIPY to the neutrophils (12) . Furthermore, RsLPS blocks the entry of toxic ReLPS through the plasma membrane into the intracellular organelles. However, the details of the interaction of RsLPS with the cell and its internalization pathway have not been defined (12) .
Microscopy has become a very important tool for studying LPS/ cell interaction in biological systems. The interaction of LPS with mammalian cells has been visualized by using immunogold labeling techniques followed by electron microscopic analysis (13) (14) (15) (16) (17) (18) (19) . Although this method has helped identify the localization of LPS inside the intracellular organelles, some uncertainties in data interpretation may arise as the result of nonspecific interactions with Abs. Moreover, Abs may not reach LPS inside invaginations of the plasma membrane. The other approach used for visualization of LPS interaction with mammalian cells is the covalent labeling of LPS with fluorescent labels followed by confocal microscopy (12, 18 -22) . This method provides information regarding the general cell distribution of LPS but does not examine the important details of its intracellular localization. Also, chemically modified fluorescent dyes linked to LPS may alter its biological activity and affinity of LPS to cells. Additionally, the LPS conjugation sites for fluorescent probes are unknown, and contaminants may be labeled. Colloidal gold is a very common inert label that has been used extensively for labeling different classes of ligands and proteins to study their interaction and localization within the cell by electron microscopy (23) (24) (25) . In nearly all instances, the conjugation of colloidal gold particles with Abs, ligands, or enzymes does not change their binding or biological activity (25) . To date, there have been no reports in the literature on direct labeling of spectrally pure ReLPS and RsDPLA with colloidal gold, probably because of their commercial unavailability and insolubility in water.
In the present study, we have developed the method for direct labeling of both ReLPS (agonist) and RsDPLA (antagonist) with colloidal gold of different particle sizes. Binding and localization of ReLPS and RsDPLA were compared within the cell by transmission and scanning electron microscopy because internalization pathway and intracellular distribution of RsDPLA has not been established yet. A side-by-side quantitative comparison of both ReLPS (agonist) and RsDPLA (antagonist) fate in the cell is extremely important for understanding of mechanisms involved in antagonism exhibited by RsDPLA.
Our data indicate that binding and internalization of ReLPSgold conjugates occurs within seconds and that an excess of RsDPLA blocks both of these processes in RAW 264.7 cells. ReLPS internalization proceeds not only via all three proposed pathways, such as clathrin-coated pits, micropinocytosis, and macropinocytosis, but also by nonspecific endocytosis into the cytoplasm. However, RsDPLA is internalized predominantly by macropinocytosis.
Materials and Methods
Reagents "Spectrally pure" ReLPS and RsDPLA were prepared and structurally characterized as described by Qureshi et al. (26, 27) . Without this level of spectral purity, contaminating phospholipids and proteins in LPS preparations may confound the results (7) . DMEM containing glucose and glutamine, FBS, and gentamicin sulfate were purchased from BioWhittaker (Walkersville, MD). Triethylamine (TEA), MES, HEPES, and trisodium citrate were obtained from Sigma (St. Louis, MO). Electron microscopygrade acetone and a Durcopan ACM embedding kit were purchased from Polysciences (Warrington, PA), and 25% glutaraldehyde and osmium tetroxide were obtained from Electron Microscopy Sciences (Fort Washington, PA). Siliconized-flat top microtubes were obtained from Fisher Scientific (Pittsburgh, PA). All glassware and plasticware were rendered pyrogen-free by heating at 120°C overnight.
Cells
Murine RAW 264.7 cells (ATCC TIB 71) were purchased from American Type Culture Collection (Manassas, VA) and cultured in DMEM, 90%; FBS, 10%; and 100 g/ml gentamicin (BioWhittaker).
Preparation of the ReLPS-gold (30 nm) conjugates and RsDPLA-gold (30 nm) conjugates
A novel method for direct 30-nm gold labeling of both ReLPS and RsDPLA has been developed. For preparation of ReLPS-gold conjugates, ReLPS, (120 l; 2.7 mg/ml) suspended in 43 mM TEA in water was mixed rapidly with 30-nm colloidal gold (0.6 ml) in 20 mM MES, pH 6.25, and sonicated for 10 min. For preparation of RsDPLA-gold conjugates, RsDPLA (120 l; 3.8 mg/ml) suspended in 24 mM TEA in water, was rapidly mixed with 0.6 ml of 30-nm colloidal gold in 20 mM MES, pH 6.67, and sonicated for 10 min. The gold aggregation test (28) was performed to detect salt-induced colloidal gold aggregation, and no free gold was present in the labeling suspensions after ReLPS-or RsDPLA-gold conjugates were prepared.
Purification of the ReLPS-gold (30 nm) conjugates
ReLPS-gold conjugates (0.5 ml) were centrifuged at 2000 rpm for 1 h in siliconized microtubes (Fisher Scientific) to remove the excess of ReLPS. ReLPS-gold conjugates were precipitated, and ReLPS not associated with gold particles remained in the supernatant. The pellet was resuspended in the 20 mM MES/20 mM TEA, pH 6.5, and conjugates proved to be stable by the gold aggregation test. The concentration of ReLPS in purified gold conjugates was determined by the phosphorus assay (29) .
Preparation of the ReLPS-gold (5 nm) conjugates and RsDPLAgold (5 nm) conjugates
For preparation of ReLPS-gold conjugates, ReLPS (90 l; 4.0 mg/ ml) suspended in 43 mM TEA in water was mixed rapidly with 5-nm colloidal gold (1.8 ml) in 20 mM HEPES, pH 7.3, and sonicated for 10 min. To prepare RsDPLA-gold conjugates, RsDPLA (170 l; 1.5 mg/ml) suspended in 18 mM TEA in water was mixed rapidly with 2.0 ml of 5-nm colloidal gold in 20 mM HEPES, pH 7.3, and sonicated for 10 min.
Purification of the ReLPS-gold (5 nm) conjugates and RsDPLAgold (5 nm) conjugates
ReLPS-and RsDPLA-gold conjugates (1.8 ml each) were centrifuged at 20,000 rpm for 1 h in a Beckman LE-80 Ultracentrifuge (Beckman Instruments, Fullerton, CA) to remove excess ReLPS/RsDPLA present in the supernatant. Precipitated gold conjugates were resuspended in 20 mM HEPES, pH 7.3. Purified ReLPS-and RsDPLA-gold conjugates were stable as determined by gold aggregation test. The concentration of ReLPS and RsDPLA in purified gold conjugates was determined by the phosphorus assay (29) .
Larger-size gold (30 nm) conjugates with toxic ReLPS (ReLPS-gc) and its antagonist RsDPLA (RsDPLA-gc) were used to quantify their binding and internalization in RAW 264.7 cells. For a qualitative and quantitative (200 -250 cells) comparison of the major differences in the pathway and distribution of ReLPS and RsDPLA within the RAW 264.7 cell, purified 5-nm gold conjugates of ReLPS and RsDPLA were used.
TNF-␣ bioassay
The assay was performed with murine RAW 264.7 cells treated with equivalent concentrations of unconjugated ReLPS or gold conjugated ReLPS. Briefly, 0.5 ml of RAW 264.7 cell culture (10 6 cell/ml) in DMEM supplemented with 10% FBS and 100 g/ml gentamicin were seeded in 12-well flat-bottom plates and incubated for 1 h at 37°C in a humidified 5% CO 2 environment. Medium then was replaced with 0.5 ml of medium containing serial dilutions of unconjugated ReLPS or gold-conjugated ReLPS in a range from 0.1 pg/ml to 10 ng/ml and incubated for 4 h at 37°C in a 5% CO 2 humidified incubator. Supernatants then were removed and analyzed for quantity of TNF-␣ according to the directions provided with the Quantikine M mouse TNF-␣ immunoassay kit (R&D Systems, Minneapolis, MN) with a CERES UV900HDi (Bio-Tek Instruments, Winooski, VT) plate reader.
Field-emission scanning electron microscopy
RAW 264.7 macrophages were grown at 37°C in DMEM medium supplemented with 10% FBS and 100 g/ml gentamicin on 200 mesh formvarcoated nickel grids (Ted Pella, Redding, CA) for 48 h. Cells were either incubated for 10 min with 5 g/ml ReLPS-gold conjugates, or pretreated with a 100-fold excess of RsDPLA, before ReLPS-gold conjugates, and incubated at 37°C for 10 min. Unbound ReLPS was removed by washing cells with DMEM and PBS (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.4). Cells were fixed with 1% glutaraldehyde in PBS for 30 min, and dehydrated in a graded series of alcohol for 5 min each, followed by drying according to the critical point drying method using a Samdri-780 (Tousimis Research, Rockville, MD) as described by Albrecht and MacKenzie (30) . Grids with the attached cells were platinum coated on IBS/ TM200 Ion-beam sputter-coating device (VCR Group, South San Francisco, CA). Samples were viewed on a Field-Emission Scanning Electron Microscope Hitachi S-900 (Hitachi Instruments, Santa Clara, CA). Micrographs were recorded on Polaroid type 55 P/N films (Polaroid, Cambridge, MA) at direct magnifications. Gold particles associated with the cells were counted on each of the 10 cells and an average amount calculated for each sample.
Transmission electron microscopy
RAW 264.7 macrophages were grown at 37°C in DMEM supplemented with 10% FBS on 4-mm mica discs for 72 h. ReLPS or RsDPLA-gold conjugates at various concentrations were mixed with the warmed medium, added to the cells, and incubated for the indicated time intervals at 37°C or 4°C. Unbound ReLPS or RsDPLA-gold conjugates were removed by washing cells with DMEM and PBS and cultures then were plunge-frozen in liquid ethane. Cryosubstitution was done with 1% osmium tetroxide in acetone according to the method of Rebhun (31) . Discs with the cells were embedded into resin Durcopan ACM (Polysciences). Thin sections of ϳ80 nm were cut with a diamond knife on a Reichert-Jung Ultracut E (ReichertJung, Vienna, Austria), transferred to 200 mesh copper grids, and stained with the lead citrate. Samples were viewed on a transmission electron microscope (CM120 STEM; Philips Electronics, Eindhoven, The Netherlands) at 60 -80 kV accelerating voltage. The number of ReLPS-or RsDPLA-gold conjugates per 10 m (presumed size of the average cell) was calculated by counting the number of cell-associated gold particles in different organelles in each of the 130 randomly selected cells' sections.
Results

Characterization of ReLPS-and RsDPLA-gold conjugates
ReLPS and RsDPLA were directly labeled with 5-nm and 30-nm colloidal gold particles for a comparative study of their interaction and localization within the cell. ReLPS-and RsDPLA-gold conjugates were purified by centrifugation, and excess nonconjugated LPS or RsDPLA was removed. With a phosphorus assay (29) , the concentration of ReLPS and RsDPLA in purified gold conjugates was estimated to be 30 and 80 molecules of ReLPS and RsDPLA, respectively, bound to one 5-nm gold particle. The binding to one 30-nm gold particle was two orders of magnitude higher (3000 -8000 molecules), which is roughly equivalent to the ratio of surface areas for 30-and 5-nm gold particles.
To determine whether the association of ReLPS with the colloidal gold would inhibit the stimulatory activity of ReLPS, the activities of gold-labeled and unlabeled ReLPS were compared. We have observed a very similar TNF-␣ response in RAW 264.7 cells (Table I ) treated with equivalent concentrations of either nonconjugated or gold-conjugated ReLPS (5-or 30-nm gold conjugates did not show any difference in activity). Therefore, we used colloidal gold as the label, because in previous studies it was shown that picogram concentrations of LPS coated on latex beads generated less than 50% of soluble LPS induction of procoagulant activity in cultured monocytes (32) . The effect was probably attributable to the relatively large size of latex beads (0.114 m) used in that study. As seen from Table I , the ratio of TNF-␣ stimulating activity for gold-conjugated ReLPS vs nonconjugated ReLPS varied from 0.89 to 0.99 as the concentration of ReLPS increased from 0.2 pg/ml up to 220 pg/ml (Table I) .
There is no possibility of presence of free gold in the ReLPS-or RsDPLA-gold conjugated preparations as observed by the gold aggregation test (28) . Therefore, we did not use the unconjugated colloidal gold particles as a control because as a hydrophobic sol, they are unstable (25) . Free gold particles tend to aggregate in a buffer or conjugate with mixed molecular species when various species are present in the suspension.
Localization of ReLPS-30-nm gold conjugates
We used transmission electron microscopy for the morphological evaluation of the distribution of ReLPS-gold conjugates in the RAW 264.7 cells. It previously was shown that ReLPS activates kinases in macrophages within seconds (33) . We found that by 30 s, 78% of the cell-associated ReLPS-gold conjugates were on the cell surface, and 22% were internalized as shown in Fig. 2A . The majority (73%) of the internalized ReLPS-gold conjugates were present within early endosomes or caveolae (nonclathrincoated; Fig. 2B ) by a process termed micropinocytosis or were found in the cytoplasmic matrix. Some gold particles also were observed in coated pits. The remaining 27% of internalized ReLPS-gold were found in large (200 -800 nm) macropinosomes or phagosome-like vacuoles, with all gold particles adhering to the limiting membrane, as shown in Fig. 2C .
Similarly, after a 5-min incubation with purified ReLPS-gold conjugates (30 nm; see Materials and Methods) 32% (220 gold particles) of conjugates were on the plasma membrane surface and 68% were internalized in the cell (Fig. 2A) . In contrast, cells that were incubated with purified ReLPS-gold conjugates at 4°C (to eliminate phagocytosis of ReLPS that occurs at 37°C), had 100% (230 gold particles) of conjugates on the membrane surface, and there was no internalization of ReLPS. When the incubation of cells with ReLPS-gold conjugates was continued for 10 min at 37°C, the amount of cell surface-associated ReLPS-gold conjugates remained the same; however, we observed the ReLPS-gold conjugates not only in the organelles mentioned above, but also in dense lysosome-like structures in the cytoplasm. The entry of a single ReLPS-gold conjugate and the formation of caveolae and endosomes as observed by transmission electron microscopy are shown in Fig. 3 . This figure shows that the LPS binds to the cell surface followed by membrane invagination and the formation of caveolae and endosomes by a process called micropinocytosis.
Localization of RsDPLA-gold conjugates
In contrast to ReLPS, no internalization was observed during the first 30 s of incubation of RsDPLA-gold conjugates with cells. The binding and internalization of RsDPLA-gold conjugates were slower compared with ReLPS-gold conjugates as could be seen from comparison of their kinetics of binding and internalization (data not shown). RsDPLA-gold conjugates were not observed in clathrin-coated vesicles, and Ͼ90% of internalized conjugates were localized in large macropinosomes or vacuoles with all gold particles adhering to the limiting membrane after 5 min as shown in Fig. 2C for ReLPS-gold conjugates. The remaining 8% of conjugates were observed in endosomes and caveolae, suggesting that RsDPLA internalization probably proceeds primarily by macropinocytosis. After 20 min of incubation, RsDPLA-gold conjugates were present inside the secondary lysosomes and the residual bodies of the cell (Fig. 4) . After 40 min of incubation, the number of RsDPLA-gold conjugates increased in the secondary lysosomes, and 3% were evident in the Golgi apparatus (Fig. 4) .
Binding and internalization of the ReLPS and RsDPLA conjugated with 5-nm gold
The lack of clathrin-coated vesicle formation during ReLPS and RsDPLA internalization described above could be attributed to large-sized conjugates made with 30-nm gold. To determine whether the size of ReLPS and RsDPLA gold conjugates can alter the pathway of their binding and internalization, purified ReLPS-5-nm gold conjugates and RsDPLA-5-nm gold conjugates were FIGURE 2. Representative electron micrography showing the sites of localization of ReLPS-gold conjugates in RAW 264.7 cells. RAW 264.7 cells were grown on 4-mm mica discs and were incubated at 37°C with 89 g/ml ReLPS-gold conjugates and washed with DMEM and PBS followed by plunge freezing in liquid ethane. Cryofixation and cryosubstitution was done with 1% osmium tetroxide in acetone, and discs with cells then were embedded into resin Durcopan ACM and processed further for transmission electron microscopy analysis. The numbers of each conjugate per 10 m (presumed size of the average cell) were calculated by viewing thin sections (80 nm) and counting the number of cell-associated gold particles in 130 randomly selected cells. Arrows indicate positions of ReLPS-gold conjugates. ReLPS-gold conjugates were localized on the membrane surface (A), in caveolae and endosomes (B), and in vacuoles (C). compared for their interaction with cells after 2 min of incubation (Fig. 5) .
When cells were treated at 37°C with 260 ng/ml purified conjugates of ReLPS-5-nm gold conjugates for 2 min, 51% of conjugates were found on or in the plasma membrane, and 49% (or 235 gold particles) were internalized. But when cells were incubated for the same time with 260 ng/ml RsDPLA-5-nm gold conjugates, 77% of gold particles were found on or in the plasma membrane, and 23% of conjugates were internalized (Fig. 5) .
By using transmission electron microscopy, we were able to distinguish ReLPS-5-nm gold conjugates associated with plasma membrane as located on the top of plasma membrane (11%), in coated pits (10%), or that which seemed to be located inside the plasma membrane or right under it (30%). At the same time, 52% of all plasma membrane-associated RsDPLA-5-nm gold conjugates were seen on the top of plasma membrane, 2.2% were found in coated pits, and 23% were located inside the plasma membrane or immediately under it.
Thirty-seven percent of all ReLPS-5-nm gold conjugates were found in the cytoplasmic matrix of the cell, and some of the conjugates were located in noncoated vesicles and vacuoles (Fig. 5) .
Fewer ReLPS-5-nm gold conjugates were found in caveolae; however, no conjugates were present in clathrin-coated vesicles. The total number of ReLPS-5-nm gold conjugates associated with the cell was 476. When we treated cells with 10ϫ lower concentration (26 ng/ml) of ReLPS-5-nm gold conjugates, we found the same distribution of conjugates within the cell as above, and the total number of ReLPS-5-nm gold conjugates associated with the cell was 52.
After a 2-min treatment of cells with 260 ng/ml purified RsDPLA-5-nm gold conjugates we found a total of 1543 purified RsDPLA-5-nm gold conjugates associated with each cell, which is three times more than those observed with ReLPS-5-nm gold conjugates. Only 5% of conjugates were found in the cytoplasmic matrix, and only a small percentage of conjugates were found in noncoated vesicles and phagosomes as observed with ReLPS-5-nm gold conjugates (Fig. 5) . We did not find any RsDPLA-5-nm gold conjugates in clathrin-coated vesicles.
Therefore, the major difference in distribution of the ReLPS-vs RsDPLA-5-nm gold conjugates within the cell after a 2-min incubation was that ReLPS-gold conjugates were present in greater numbers in the cytosol (7-fold) and in coated pits (5-fold) as compared with RsDPLA, whereas the distribution among other organelles appeared similar.
RsDPLA blocks the binding and internalization of ReLPS-gold conjugates
Previously, an excess of RsDPLA has been shown to block ReLPS cell-stimulating activity (8) . We found 21 ReLPS-gold conjugates on the membrane surface and 27 inside the cell without RsDPLA treatment. When RAW 264.7 cells were pretreated with an excess of RsDPLA (not labeled with gold) and then incubated with 5 g/ml ReLPS-gold conjugates and examined by thin-section transmission electron microscopy, no gold particles were present on the cell surface or inside the cell. When purified ReLPS-gold conjugates for the same experiment were used, 37 purified ReLPS-gold conjugates were present on the membrane surface and 81 were inside the cell. In the presence of RsDPLA, only one ReLPS-gold conjugate per cell was located at the cell plasma membrane surface (Table II) . These experiments illustrate that RsDPLA completely blocks the binding of LPS and thus its entry into the cell.
Scanning electron microscopy also was also used to evaluate the antagonistic properties of RsDPLA, and similar results were observed. In the absence of RsDPLA, 17 ReLPS-gold conjugates a RAW 264.7 macrophages were grown on 4-mm mica discs and incubated with 5 g/ml ReLPS-gold conjugates (ReLPS-gc), for 2 min at 37°C. These cells were washed with DMEM and PBS and plunge frozen in liquid propane. Cryosubstitution was done with 1% osmium tetroxide in acetone, and then the discs with cells were embedded into resin Durcopan ACM and processed further for TEM analysis. The number of ReLPS-gold conjugates per 10 m (presumed size of the average cell) was calculated by viewing thin sections (80 nm) and counting the cell-associated gold particles in 130 randomly selected cells.
b Cells were preincubated for 20 min with 364 g/ml RsDPLA. c Purified ReLPS-gold conjugates were prepared by centrifugation, and the concentration of conjugated ReLPS concentration was 250 ng/ml as determined by the phosphorus assay (29) .
d Purified ReLPS-gold conjugates were prepared by centrifugation, and the concentration of ReLPS in the experiment as determined by phosphorus assay (29) was 150 ng/ml. e RsDPLA concentration was 9 g/ml.
bound to or incorporated into the cell plasma membrane after 10 min of incubation (Figs. 6 and 7). In Fig. 6B , one ReLPS-gold conjugate was on the surface and one entered the cell. In Fig. 7A , ReLPS-gold conjugates (white dots) were observed on the cell surface. However, in the presence of excess RsDPLA, ReLPS-gold conjugates failed to bind the cell. These results indicate that RsDPLA blocks the ReLPS activation of cells by blocking access to the binding sites on the cell surface and thus preventing its internalization into the cell.
Discussion
RsDPLA is an effective antagonist in both human and murine cell types (8) . RsDPLA has been shown to bind to soluble CD14 and LBP (10) and blocks the induction of TNF-␣ and IL-1␤ (8) .
RsDPLA also blocks the LPS-induced tyrosine phosphorylation in macrophages and protects mice against the lethal effects of toxic LPS (8) . However, the blockade of the LPS binding sites on the cell surface by LPS antagonists has never been demonstrated by electron microscopy. There have been several technical problems in the past. Previously, gold-labeled Abs to LPS have been used to track the LPS in the cell, and these results are not reliable. LPS is often contaminated with proteins (7) that can easily bind to gold particles, and conjugation of gold particles to spectrally pure aggregated LPS has been difficult. We have now developed a method for complexing different-sized gold particles with purified and protein-free ReLPS and RsDPLA.
In the present study, spectrally pure ReLPS from E. coli was used (27) . Spectrally pure ReLPS allowed colloidal gold to bind the LPS and not contaminating proteins, which would have been the case had commercial preparations of ReLPS been used. Stable ReLPS and RsDPLA-gold conjugates with 5-nm and 30-nm colloidal gold particles were prepared, and the activities of both goldlabeled and unlabeled ReLPS were compared. Both gold labeled and unlabeled samples induced similar TNF-␣ responses in RAW 264.7 cells (Table I) , thus indicating that gold does not affect the biological activity of the LPS. This is not surprising because in nearly all instances, the conjugation of colloidal gold particles with Abs, ligands, or enzymes does not change their binding or biological activity (25) .
Binding of LPS to the plasma membrane is an essential initial step for interaction between LPS and the cell. LPS enters the cell via three different mechanisms as proposed recently: formation of the clathrin-coated vesicles (14) ; macropinocytosis similar to bacterial phagocytosis (18) ; and via noncoated plasma membrane invaginations involving caveolae and micropinocytosis leading to the formation of micropinocytic vesicles (19) . Our data indicate that after a 2-min incubation of ReLPS with the cell, the majority of internalized ReLPS was found in the cytoplasmic matrix (Fig.   FIGURE 6 . Representative scanning electron microscopy showing ReLPS-gold conjugates located on the top of RAW 264.7 cells membrane (secondary electron image; A) and also incorporated into membrane (back-scattered electron image; B). RAW 264.7 macrophages grown on formvar film-coated nickel grids were incubated for 10 min at 37°C with 5 g/ml ReLPS-gold conjugates, washed with DMEM and PBS, fixed in 1% glutaraldehyde for 30 min, dehydrated, and dried by critical point drying procedure (see Materials and Methods). The white dots are ReLPS-gold conjugates.
FIGURE 7.
Representative scanning electron microscopy images of interaction of ReLPS-gold conjugates with RAW 264.7 cells in the absence and in the presence of RsDPLA. RAW 264.7 macrophages grown on formvar film-coated nickel grids were incubated for 10 min at 37°C with 5 g/ml ReLPS-gold conjugates (A) in the absence or (B) in the presence of 100-fold excess of RsDPLA. Grids were washed with DMEM and PBS, fixed in 1% glutaraldehyde for 30 min, dehydrated, and dried by critical point drying procedure (see Materials and Methods). Quantity of ReLPS-gold conjugates per cell was calculated by counting the number of cell-associated gold particles in 10 randomly selected cells. The white dots are ReLPS-gold conjugates. 5 ), but as the incubation time increased ReLPS was found primarily in macropinosomes and phagosomes (data not shown). This observation suggests that ReLPS internalization proceeds not only via all three earlier proposed pathways, but it also can penetrate through plasma membrane of the cell by an unknown mechanism.
We have shown previously that RsDPLA has 10 5 times lower TNF-stimulating activity as compared with ReLPS (9) and is the potent LPS antagonist in both human and murine cells (8) . But internalization pathway and intracellular distribution of RsDPLA within the cell has not been established yet. A side-by-side quantitative comparison of both ReLPS and RsDPLA fate in the cell is extremely important for understanding the mechanisms involved in antagonism exhibited by RsDPLA. RsDPLA was internalized predominantly via macropinocytosis and phagocytosis as evident from our data. The internalized RsDPLA-gold conjugates were found mostly in large vacuoles as described by Yoshida et al. (34) with all gold particles adhering to the limiting membrane (Fig.  4C) . We did not observe any clathrin-coated vesicles carrying RsDPLA-gold conjugates.
ReLPS (agonist) and RsDPLA (antagonist) bind to the cell plasma membrane, and both can be internalized via macropinocytosis. The main difference is that ReLPS also can be internalized via other pathways; in addition, the majority of ReLPS was found in the cytoplasmic matrix, whereas RsDPLA was very rarely observed in the cytoplasm (Fig. 5) . The mechanism by which RsDPLA and ReLPS are internalized may be different: ReLPS internalization proceeds by both micropinocytosis and macropinocytosis (18) and endocytosis into the cytoplasm, whereas RsDPLA internalization proceeds predominantly by macropinocytosis. These results are consistent with Kitchens et al. (19) , who showed that LPS aggregation promotes accelerated monocyte entry via a noncoated pathway. We did not detect ReLPS-or RsDPLA-gold conjugates in the mitochondria, nucleus, or peroxisomes, which is consistent with the data of Kriegsmann et al. (15) .
Our data revealed that an excess of RsDPLA blocks both the binding and internalization of ReLPS (Table II and Fig. 7) . The fact that RsDPLA binds to the cell and prevents ReLPS binding suggests that they are competing for the same binding sites. These findings support the mechanism for RsDPLA antagonism suggested by Qureshi et al. (8) : RsDPLA binds to LBP, CD14, and possibly other signaling protein(s) on cells. TLR-4, TLR-2, and MD-2 recently have been suggested to be the signaling proteins (2-4). TLR-4 has been suggested to be the central lipid A-recognition protein in the LPS receptor complex (34) . However, LPS has not been shown to bind strongly to these proteins. LBPs other than CD14 present on cells remain to be determined. RsDPLA competes for the LPS binding site on LBP (10) . The RsDPLA-LBP complex then competes with LPS-LBP complex at the second level of binding with membrane CD14. RsDPLA also may compete at the third level of binding at the LPS signaling protein (TLR-4) level (35) . Therefore, RsDPLA prevents the binding of ReLPS to CD14 or other proteins on the cell surface. However, RsDPLA, with fewer and shorter fatty acyl chains, binds to the cell but is unable to initiate cell activation, and thus acts as an LPS antagonist. The importance of LPS internalization and the fate of LPS inside the cell are presently not known. Future studies are required to clarify LPS interaction with host organelles.
